Credentials
Positions
- Professor, Department of Cell Biology at NYU Grossman School of Medicine
- Leon H. Charney Professor of Cardiovascular Medicine, Department of Medicine at NYU Grossman School of Medicine
- Professor, Department of Microbiology at NYU Grossman School of Medicine
- Professor, Department of Pediatrics at NYU Grossman School of Medicine
- Director, Bell Prog Vas Bio & Dis Prev & Res Ctr
Board Certifications
- American Board of Pediatrics - Pediatrics, 1981
Education and Training
- Fellowship, NIH - National Institute of Health, Medical Genetics, 1984
- Fellowship, Boston Children's Hospital, Gastroenterology, 1982
- PhD from Massachusetts Inst of Tech, 1982
- MPH from UNC-Chapel Hill, 1978
- Residency, Duke University Hospital, Pediatric Medicine, 1977
- MD from New York University, 1975
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
-
Aetna
- Aetna HMO
- Aetna Indemnity
- Aetna Medicare
- Aetna POS
- Aetna PPO/EPO
-
Blue Cross Blue Shield
- Empire BCBS
- Empire BCBS Top Tier
-
Cigna
- Cigna EPO/POS
- Cigna PPO
-
Emblem
- Emblem Select Care Exchange
-
Empire Blue Cross Blue Shield
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield HealthPlus
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield MediBlue
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
-
GHI
- GHI CBP
- GHI HMO
-
HIP
- HIP Access I
- HIP Access II
- HIP Child Health
- HIP EPO/PPO
- HIP HMO
- HIP Medicaid
- HIP Medicare
- HIP POS
-
Healthfirst
- Healthfirst
-
Humana
- Humana Medicare
-
Local 1199
- Local 1199 PPO
-
MagnaCare
- MagnaCare PPO
-
Medicare
- Medicare
-
MetroPlus
- MetroPlus Child Health
- MetroPlus Exchange Plans
- MetroPlus Medicaid
- MetroPlus Medicare
-
MultiPlan/PHCS
- MultiPlan/PHCS PPO
-
NYS Health Insurance Plan
- The Empire Plan
-
Oxford
- Oxford Freedom
- Oxford Liberty
- Oxford Medicare
-
Railroad Medicare
- Railroad Medicare
-
Tricare
- Tricare
-
UHC
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare Medicare
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
-
UPN
- UPN Elite
-
WTC Health Program
- WTC Health Program
Edward A. Fisher, MD, MPH, PhD does not accept insurance.
Locations and Appointments
NYU Langone Cardiology Associates
530 1st Avenue, HCC 5th Floor, New York, NY 10016
Research My Research
Interests
Atherosclerosis, Macrophages, Inflammation, Lipoproteins, Diabetes, Obesity
Research Summary
Molecular and immunologic determinants of the factors causing atherosclerosis and cardiovascular disease
Our laboratory has a longstanding interest in two major areas. One is the cell biology of the assembly and secretion of the macromolecular complexes that transport lipids (mainly triglycerides and cholesterol) made in the liver to other tissues, where they are used for a number of essential purposes. Some of the strongest risk factors for cardiovascular disease—the leading killer not just in the U.S., but worldwide—are related to the levels of certain lipoproteins in the blood. Thus, information about the mechanisms on how they are formed is of great value in understanding how to regulate the levels of the cardiovascular disease-causing lipoproteins. Recently, we have discovered factors that coregulate lipoprotein assembly and secretion and the formation of the types of lipid droplets that can accumulate to cause “fatty liver”, a serious and increasingly common health problem associated with obesity.
The other major research area is the underlying cause of cardiovascular disease, namely atherosclerosis, the buildup of cholesterol-filled cells that form plaques, such as in the coronary arteries. These plaques can rupture and cause a heart attack. We have pioneered mouse models of atherosclerosis and molecular approaches so that we can discover the key factors that will return a diseased artery back to a healthier state. We have discovered that reducing the levels in the blood of certain lipoproteins coupled with resolving the inflammation of the immune cells in the plaques is the optimal combination to achieve this. We are extending these studies to the molecular level to identify specific therapeutic targets as well as to human plaques and to clinically relevant conditions known to increase plaque inflammation and the risk of cardiovascular disease, such as obesity, insulin resistance, and diabetes.
Research Interests Timeline
Publications
-
Schlegel, Martin; Cyr, Yannick; Newman, Alexandra A C; Schreyer, Korbinian; Barcia Durán, José Gabriel; Sharma, Monika; Bozal, Fazli K; Gourvest, Morgane; La Forest, Maxwell; Afonso, Milessa S; van Solingen, Coen; Fisher, Edward A; Moore, Kathryn J
Proceedings of the National Academy of Sciences of the United States of America. 2024 Oct 29; 121(44):e2412690121
-
Wang, Haizhen; Nikain, Cyrus; Fortounas, Konstantinos I; Amengual, Jaime; Tufanli, Ozlem; La Forest, Maxwell; Yu, Yong; Wang, Meng C; Watts, Russell; Lehner, Richard; Qiu, Yunping; Cai, Min; Kurland, Irwin J; Goldberg, Ira J; Rajan, Sujith; Hussain, M Mahmood; Brodsky, Jeffrey L; Fisher, Edward A
Molecular metabolism. 2024 Oct 18; 102048
-
Brodsky, Jeffrey L; Iyer, Anuradha; Fortounas, Konstantinos I; Fisher, Edward A
Current opinion in lipidology. 2024 Oct 01; 35(5):248-252